Detalles de la búsqueda
1.
B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma.
Blood
; 132(17): 1805-1817, 2018 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30209121
2.
Constitutive BR3 receptor signaling in diffuse, large B-cell lymphomas stabilizes nuclear factor-κB-inducing kinase while activating both canonical and alternative nuclear factor-κB pathways.
Blood
; 117(1): 200-10, 2011 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-20889926
3.
The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapies.
Semin Cancer Biol
; 21(5): 308-12, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-21945516
4.
An epigenetic chromatin remodeling role for NFATc1 in transcriptional regulation of growth and survival genes in diffuse large B-cell lymphomas.
Blood
; 116(19): 3899-906, 2010 Nov 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-20664054
5.
Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting.
Blood
; 113(19): 4604-13, 2009 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-19228923
6.
BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.
Blood
; 113(19): 4627-36, 2009 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-19258594
7.
IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.
Blood
; 114(2): 360-70, 2009 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-19423729
8.
Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination.
J Cell Mol Med
; 14(6B): 1532-45, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19656242
9.
The Role of Macrophage/B-Cell Interactions in the Pathophysiology of B-Cell Lymphomas.
Front Oncol
; 8: 147, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29868471
10.
Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma.
Oncotarget
; 9(1): 346-360, 2018 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29416618
11.
Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas.
Clin Cancer Res
; 24(16): 3967-3980, 2018 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29666304
12.
Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.
Oncotarget
; 7(49): 80599-80611, 2016 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27716624
13.
Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.
J Hematol Oncol
; 8: 121, 2015 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26515759
14.
Involvement of tumor-associated macrophage activation in vitro during development of a novel mantle cell lymphoma cell line, PF-1, derived from a typical patient with relapsed disease.
Leuk Lymphoma
; 56(1): 186-93, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24611650
15.
Quantitative real-time polymerase chain reaction for monitoring minimal residual disease in patients with advanced indolent lymphomas treated with rituximab, fludarabine, mitoxantrone, and dexamethasone.
Semin Oncol
; 29(1 Suppl 2): 48-55, 2002 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-11842389
16.
Cellular pharmacology of P-ethoxy antisense oligonucleotides targeted to Bcl-2 in a follicular lymphoma cell line.
Leuk Lymphoma
; 44(11): 1979-85, 2003 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-14738153
17.
Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma.
Leuk Lymphoma
; 43(8): 1589-98, 2002 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12400601
18.
Managing lymphoma with non-FDG radiotracers: current clinical and preclinical applications.
Biomed Res Int
; 2013: 626910, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23841079
19.
Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.
Exp Hematol
; 41(1): 67-78.e4, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22986101
20.
In vitro and in vivo therapeutic efficacy of carfilzomib in mantle cell lymphoma: targeting the immunoproteasome.
Mol Cancer Ther
; 12(11): 2494-504, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23990113